Cytokinetics Inc. buy Citigroup Inc.
Start price
22.12.25
/
50%
€55.50
Target price
22.12.26
-
Performance (%)
19.46%
Price
15:34
€66.30
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ currently has a performance of 19.46%. This prediction currently runs until 22.12.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -5.803% | -5.803% |
| iShares Core DAX® | 2.591% | 2.467% |
| iShares Nasdaq 100 | -0.915% | -6.458% |
| iShares Nikkei 225® | 0.145% | -8.773% |
| iShares S&P 500 | -0.367% | -1.220% |
Comments by Citigroup_Inc_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.40
07.05.25
07.05.25
€70.52
07.05.26
07.05.26
112.86%
08.05.26
08.05.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€43.80
07.02.25
07.02.25
€82.96
07.02.26
07.02.26
21.00%
08.02.26
08.02.26